Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06895785 · ClinicalTrials.gov registry record · NA
Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial
A NA study of Biliary Diseases and Pancreatic Duct Disorder, sponsored by Rush University Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06895785: Recruiting NA study of Biliary Diseases and Pancreatic Duct Disorder, sponsored by Rush University Medical Center.
NCT06895785 is a NA study of Biliary Diseases and Pancreatic Duct Disorder that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06895785, a NA study of Biliary Diseases and Pancreatic Duct Disorder, is actively recruiting participants, sponsored by Rush University Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized controlled trial (RCT) is designed to evaluate the new generation Exalt Model disposable duodenoscope compared to the reusable scope in terms of feasibility, ease of use, adverse events, number of crossover events, and infection rates.
Primary Outcome
Measure and compare the total number of attempts required to achieve successful cannulation of the desired duct.
Conditions Studied
Interventions
- DEVICE Exalt Model D
- DEVICE Reusable
Study Locations (1)
Illinois
- Rush University Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-02-21 |
| Est. Completion | 2030-05 |
| Phase | NA |
What NCT06895785 shows while recruiting
NCT06895785 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Biliary Diseases appearing as the primary indexed condition, and to 2 interventions - of which Exalt Model D is the first listed.
NCT06895785 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06895785 about?
NCT06895785 is a clinical study titled "Exalt Single-use Duodenoscope Vs Reusable Scope, a Randomized Controlled Trial". This randomized controlled trial (RCT) is designed to evaluate the new generation Exalt Model disposable duodenoscope compared to the reusable scope in terms of feasibility, ease of use, adverse events, number of crossover events, and infection rates.
What is the current status of trial NCT06895785?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-02-21. Estimated completion is 2030-05.
What conditions does trial NCT06895785 study?
This clinical trial studies the following conditions: Biliary Diseases, Pancreatic Duct Disorder.
What interventions are being tested in trial NCT06895785?
The interventions under investigation include: Exalt Model D (DEVICE), Reusable (DEVICE).
Who is sponsoring clinical trial NCT06895785?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06895785 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06895785's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI